These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34304143)

  • 1. Ki-67 and p53 expression in head and neck mucosal melanoma: A clinicopathologic analysis of predictors of outcome.
    Yin G; Guo W; Liu H; Huang Z; Chen X
    Ann Diagn Pathol; 2021 Oct; 54():151789. PubMed ID: 34304143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.
    Couture C; Raybaud-Diogène H; Têtu B; Bairati I; Murry D; Allard J; Fortin A
    Cancer; 2002 Feb; 94(3):713-22. PubMed ID: 11857304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67, Bcl-2 and p53 expression in primary and metastatic melanoma.
    Ilmonen S; Hernberg M; Pyrhönen S; Tarkkanen J; Asko-Seljavaara S
    Melanoma Res; 2005 Oct; 15(5):375-81. PubMed ID: 16179864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristic and prognostic analyses of 117 cases of head and neck mucosal melanoma].
    Yin GF; Guo W; Chen XH; Liu ZY; Huang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 53(9):668-674. PubMed ID: 30293258
    [No Abstract]   [Full Text] [Related]  

  • 5. Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome.
    Lawrence NF; Hammond MR; Frederick DT; Su Y; Dias-Santagata D; Deng A; Selim MA; Mahalingam M; Flaherty KT; Hoang MP
    J Am Acad Dermatol; 2016 Sep; 75(3):595-602. PubMed ID: 27543214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical profile of oral mucosal and head and neck cutaneous melanoma.
    Alaeddini M; Etemad-Moghadam S
    J Oral Pathol Med; 2015 Mar; 44(3):234-8. PubMed ID: 25048051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study.
    Koelbl O; Rosenwald A; Haberl M; Müller J; Reuther J; Flentje M
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):147-54. PubMed ID: 11163508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
    Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
    Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis.
    Nishimura R; Osako T; Okumura Y; Tashima R; Toyozumi Y; Arima N
    World J Surg Oncol; 2011 Oct; 9():131. PubMed ID: 22004841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
    Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
    Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma.
    El-Gendi S; Abu-Sheasha G
    Pathol Oncol Res; 2018 Apr; 24(2):309-322. PubMed ID: 28488128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
    Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
    J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer.
    Moul JW; Bettencourt MC; Sesterhenn IA; Mostofi FK; McLeod DG; Srivastava S; Bauer JJ
    Surgery; 1996 Aug; 120(2):159-66; discussion 166-7. PubMed ID: 8751578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P; Adelstein DJ; Myles J; Secic M
    Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas.
    Hanprasertpong J; Tungsinmunkong K; Chichareon S; Wootipoom V; Geater A; Buhachat R; Boonyapipat S
    J Obstet Gynaecol Res; 2010 Jun; 36(3):572-80. PubMed ID: 20598040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of p53, proliferating cell nuclear antigen, and Ki-67 expression in undifferentiated nasopharyngeal carcinomas.
    Genç E; Hoşal AS; Gedikoğlu G; Ozyar E; Sözeri B
    Otolaryngol Head Neck Surg; 2000 Jun; 122(6):868-73. PubMed ID: 10828801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perianal Bowen's disease: a clinicopathologic study of 47 patients.
    Marchesa P; Fazio VW; Oliart S; Goldblum JR; Lavery IC
    Dis Colon Rectum; 1997 Nov; 40(11):1286-93. PubMed ID: 9369101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.